Found: 7
Select item for more details and to access through your institution.
Bacterial metabolite butyrate in modulating sorafenib-targeted microRNAs to curtail its resistance in hepatocellular carcinoma.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 9, p. 5823, doi. 10.1007/s00432-022-04544-7
- By:
- Publication type:
- Article
Circulating metabolite biomarkers: a game changer in the human prostate cancer diagnosis.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 3, p. 951, doi. 10.1007/s00432-022-04113-y
- By:
- Publication type:
- Article
Sorafenib response in hepatocellular carcinoma: MicroRNAs as tuning forks.
- Published in:
- Hepatology Research, 2018, v. 48, n. 1, p. 5, doi. 10.1111/hepr.12991
- By:
- Publication type:
- Article
Vimentin as a potential therapeutic target in sorafenib resistant HepG2, a HCC model cell line.
- Published in:
- Clinical & Molecular Hepatology, 2020, v. 26, n. 1, p. 45, doi. 10.3350/cmh.2019.0031
- By:
- Publication type:
- Article
Association of liver cirrhosis severity with type 2 diabetes mellitus in hepatocellular carcinoma.
- Published in:
- Experimental Biology & Medicine, 2018, v. 243, n. 4, p. 323, doi. 10.1177/1535370217744511
- By:
- Publication type:
- Article
Crosstalk between microRNA-122 and FOX family genes in HepG2 cells.
- Published in:
- Experimental Biology & Medicine, 2017, v. 242, n. 4, p. 436, doi. 10.1177/1535370216681548
- By:
- Publication type:
- Article
miR-23b-3p Modulating Cytoprotective Autophagy and Glutamine Addiction in Sorafenib Resistant HepG2, a Hepatocellular Carcinoma Cell Line.
- Published in:
- Genes, 2022, v. 13, n. 8, p. 1375, doi. 10.3390/genes13081375
- By:
- Publication type:
- Article